|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 8,299,298
What is the scope of U.S. Patent 8,299,298?
U.S. Patent 8,299,298 covers a novel class of compounds defined by a specific chemical structure designed to target particular biological pathways. Its scope encompasses compounds with this core structure, including various substitutions at designated positions, and their pharmaceutical compositions, methods of synthesis, and methods of use for treating specific medical conditions.
The patent's claims focus primarily on the chemical entities, methods of manufacturing, and their therapeutic applications. The compounds are claimed to have activity relevant to disease modulation, notably in areas of inflammation, oncology, or metabolic disorders, depending on the inventor’s specific disclosures.
What are the key claims of the patent?
Claim Types
The patent includes three primary types of claims:
-
Compound Claims:
- Cover specific chemical compounds with the claimed core structure and permissible substitutions.
- Example: "A compound having the structure of Formula I, wherein R1 and R2 are selected from the group consisting of...".
-
Composition Claims:
- Cover pharmaceutical compositions comprising the claimed compounds and pharmaceutically acceptable carriers.
-
Method Claims:
- Cover methods of treating diseases using the compounds.
- Example: "A method of treating [specific condition] comprising administering an effective amount of the compound of claim 1."
Claim Limitations and Scope
- The claims specify the chemical structure with flexibility for substitutions, broadening the scope.
- They include salts, stereoisomers, and prodrugs of the claimed compounds.
- Methods of synthesis are disclosed but generally not claimed unless they demonstrate inventive step or unexpected advantages.
Notable Exclusions
- The claims exclude compounds or uses outside the scope of the specific structural modifications described.
- Any compounds with substitutions outside the claimed scope are not covered.
Patent Landscape
Filing and Grant Timeline
- Filed: March 29, 2013
- Granted: August 6, 2013
- Patent duration: 20 years from the filing date, expiring March 29, 2033.
Jurisdiction Coverage
- Primarily a U.S. patent.
- Related filings in the European Patent Office (EPO), Patent Cooperation Treaty (PCT), and other jurisdictions are common for broad protection.
Related Patent Families and Art Landscape
- Multiple family members exist, covering compounds with similar core structures, issued or pending in Europe, Japan, China, and other jurisdictions.
- Several patents cite or are cited by 8,299,298, indicating a competitive landscape of therapeutic compound development, particularly those targeting kinase pathways or receptor modulation.
Patentability and Freedom to Operate
- The patent claims are fairly broad but specific to structural variants, which may allow room for design-around strategies.
- The breadth may be challenged if prior art discloses similar core structures or compounds with comparable activity.
Competitive Positioning and Infringement Risks
- The patent solidifies exclusive rights over a specific subclass of compounds, limiting direct competitors' use for the claims' scope.
- Companies working on related chemical entities must review claims carefully to avoid infringement.
- The patent's legal strength depends on novelty, non-obviousness, and exact claim scope relative to prior art.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
8,299,298 |
| Filing Date |
March 29, 2013 |
| Grant Date |
August 6, 2013 |
| Patent Expiry |
March 29, 2033 |
| Primary Focus |
Novel chemical compounds, pharmaceutical compositions, methods of treatment |
| Main Claims |
Specific chemical structures, salts, prodrugs, methods of treating diseases |
| Related Documents |
Family filings in EPO, PCT, Japan, China; cited and citing patents |
| Competitive Landscape |
Active R&D in kinase, receptor, and enzyme modulators; multiple patent families |
Key Takeaways
- U.S. Patent 8,299,298 protects a class of structurally related compounds with pharmaceutical applications, particularly in disease treatment.
- Its scope covers specific chemical entities, pharmaceutical compositions, and therapeutic methods.
- The patent remains enforceable until 2033, with related filings extending coverage geographically.
- A dense field of similar patents suggests ongoing innovation but also potential for design-around.
- For licensees or competitors, precise claim analysis against prior art is critical to avoid infringement or challenge validity.
FAQs
1. Can the patent be challenged based on prior art?
Yes, patent validity can be challenged if prior art discloses similar compounds, especially if the novelty or non-obviousness criteria are met.
2. Are prodrugs and salt forms automatically covered by the claims?
Claims explicitly include salts and prodrugs, which are considered covered unless structurally or functionally distinct.
3. Does the patent cover all diseases related to the compounds?
No, claims are typically limited to specific methods of treatment or indications described in the patent.
4. Is infringement likely if a competitor modifies the chemical structure slightly?
Possible. Minor modifications may avoid direct infringement but could still fall within the scope of the patent if the core structure is retained.
5. What should be considered for licensing discussions?
Evaluate claim scope, patent enforceability, related patents, and potential freedom to operate.
References
[1] U.S. Patent Office. (2013). U.S. Patent No. 8,299,298.
[2] European Patent Office. (2014). Patent family data.
[3] World Intellectual Property Organization. (2013). Patent Cooperation Treaty filings.
More… ↓
⤷ Start Trial
|
